Infertility with Testicular Cancer

Urologic Clinics of North America

Volumn 42, Issue 3, 2015, Pages 409-420

  Ostrowski, Kevin A ^a   Walsh, Thomas J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Male infertility; Radiation therapy; Retroperitoneal lymph node dissection (RPLND); Surveillance; Testicular cancer; Testicular germ cell tumors

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; PROCARBAZINE; SPERM ANTIBODY; THIOTEPA; VINBLASTINE;

ADOLESCENCE; AUTOIMMUNE DISEASE; AZOOSPERMIA; BLOOD TESTIS BARRIER; BODY IMAGE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CLINICAL TRIAL (TOPIC); CRYOPRESERVATION; DISEASE ASSOCIATION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; GERM CELL TUMOR; GONADAL DISEASE; HIGH RISK POPULATION; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE INFERTILITY; MALE SEXUAL DYSFUNCTION; MEDICAL HISTORY; MENTAL DISEASE; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; NONHUMAN; ORCHIECTOMY; PARAAORTIC LYMPH NODE; PHYSICAL EXAMINATION; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; RADIATION DOSE; REVIEW; SELF ESTEEM; SEMEN ANALYSIS; SEMINOMA; SPERM QUALITY; SPERMATOGONIAL STEM CELL; SPERMATOZOON COUNT; STEM CELL; STEM CELL TRANSPLANTATION; TESTICULAR DYSGENESIS SYNDROME; TESTICULAR SPERM EXTRACTION; TESTIS BIOPSY; TESTIS CANCER; TESTIS DEVELOPMENT; TESTIS DISEASE; TESTIS INJURY; TUMOR INVASION; ADAPTIVE BEHAVIOR; ADJUVANT THERAPY; ADVERSE EFFECTS; DRUG EFFECTS; FERTILITY PRESERVATION; INFERTILITY, MALE; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; ORGANS AT RISK; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; SPERMATOGENESIS; SURGERY; TESTICULAR NEOPLASMS; TESTIS;

ADAPTATION, PSYCHOLOGICAL; ANTINEOPLASTIC AGENTS; CRYOPRESERVATION; FERTILITY PRESERVATION; HUMANS; INFERTILITY, MALE; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; ORGANS AT RISK; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; SPERMATOGENESIS; TESTICULAR NEOPLASMS; TESTIS;

EID: 84938286645     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2015.05.003     Document Type: Review

References (58)

1. Huyghe E., Matsuda T., Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003, 170:5-11.
2. Spira A. Epidemiology of human reproduction. Hum Reprod 1986, 1:111-115.
3. Mosher W.D., Pratt W.F. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991, 56:192-193.
4. Ragni G., Somigliana E., Restelli L., et al. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer 2003, 97(7):1624-1629.
5. Lass A., Akagbosu F., Abusheikha N., et al. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years' experience. Hum Reprod 1998, 13:3256.
6. Bahadur G., Ozturk O., Muneer A., et al. Semen quality before and after gonadotoxic treatment. Hum Reprod 2005, 20:774.
7. Williams D.H., Karpman E., Sander J.C., et al. Pretreatment semen parameters in men with cancer. J Urol 2009, 181(2):736-740.
8. Hendry W.F., Stedronska J., Jones C.R., et al. Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol 1983, 55(6):769-773.
9. Dieckmann K.P., Linke J., Pichlmeier U., et al. Spermatogenesis in the contralateral testis of patients with testicular germ cell cancer: histological evaluation of testicular biopsies and comparison with healthy males. BJU Int 2007, 99(5):1079-1085.
10. Jacobsen R., Bostofte E., Engholm G., et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 2000, 321:789-792.
11. Walsh T.J., Croughan M.S., Schembri M., et al. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 2009, 169:351-356.
12. Marmor D., Elefant E., Dauchez C., et al. Semen analysis in Hodgkin's disease before the onset of treatment. Cancer 1986, 57(10):1986-1987.
13. Plata-Salamán C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000, 16(10):1009-1012.
14. Hotaling J.M., Lopushnyan N.A., Davenport M., et al. Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril 2013, 99(2):464-469.
15. Carroll P.R., Whitmore W.F., Herr H.W., et al. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J Urol 1987, 137(3):420-423.
16. Petersen P.M., Skakkebaek N.E., Rørth M., et al. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J Urol 1999, 161(3):822-826.
17. Fossa S.D., Theodorsen L., Norman N., et al. Recovery of impaired pretreatment spermatogenesis in testicular cancer. Fertil Steril 1990, 54(3):493-496.
18. Brennemann W., Stoffel-Wagner B., Wichers M., et al. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer. J Urol 1998, 159(6):1942-1946.
19. Sprauten M., Brydøy M., Haugnes H.S., et al. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. J Clin Oncol 2014, 32(6):571-578.
20. de Bruin D., de Jong I.J., Arts E.G., et al. Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones. Fertil Steril 2009, 91(6):2481-2486.
21. Hansen P.V., Trykker H., Andersen J., et al. Germ cell function and hormonal status in patients with testicular cancer. Cancer 1989, 64(4):956-961.
22. Paoli D., Gilio B., Piroli E., et al. Testicular tumors as a possible cause of antisperm autoimmune response. Fertil Steril 2009, 91(2):414-419.
23. Guazzieri S., Lembo A., Ferro G., et al. Sperm antibody and infertility in patients with testicular cancer. Urology 1985, 26:139-142.
24. Foster R.S., Rubin L.R., McNulty A., et al. Detection of antisperm- antibodies in patients with primary testicular cancer. Int J Androl 1991, 14:179-185.
25. Höbarth K., Klinger H.C., Maier U., et al. Incidence of antisperm antibodies in patients with carcinoma of the testis and in subfertile men with normogonadotropic oligoasthenoteratozoospermia. Urol Int 1994, 52:162-165.
26. Garner M.J., Turner M.C., Ghadirian P., et al. Epidemiology of testicular cancer: an overview. Int J Cancer 2005, 116(3):331-339.
27. Juul A., Almstrup K., Andersson A.M., et al. Possible fetal determinants of male infertility. Nat Rev Endocrinol 2014, 10(9):553-562.
28. Qiao D., Zeeman A.M., Deng W., et al. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002, 21(25):3988-3999.
29. Hotaling J.M., Walsh T.J. Male infertility: a risk factor for testicular cancer. Nat Rev Urol 2009, 6(10):550-556.
30. Langenstroer P., Rosen M.A., Griebling T.L., et al. Ejaculatory function in stage T1 nonseminomatous germ cell tumors: retroperitoneal lymph node dissection versus surveillance-a decision analysis. J Urol 2002, 168(4 Pt 1):1396-1401.
31. Carroll P.R., Morse M.J., Whitmore W.F., et al. Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol 1987, 138(1):70-72.
32. Jacobsen K.D., Theodorsen L., Fossa S.D. Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy. J Urol 2001, 165(1):93-96.
33. Brydøy M., Fosså S.D., Klepp O., et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005, 97(21):1580-1588.
34. Beck S.D., Bey A.L., Bihrle R., et al. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. J Urol 2010, 184(5):2078-2080.
35. Jacobsen K.D., Ous S., Waehre H., et al. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 1999, 80(1-2):249-255.
36. Shalet S.M. Effect of irradiation treatment on gonadal function in men treated for germ cell cancer. Eur Urol 1993, 23(1):148-151.
37. Gordon W., Siegmund K., Stanisic T.H., et al. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys 1997 Apr 1, 38(1):83-94.
38. Hansen P.V., Trykker H., Svennekjaer I.L., et al. Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiother Oncol 1990, 18(2):117-125.
39. Pont J., Albrecht W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 1997, 68(1):1-5.
40. Brydøy M., Fosså S.D., Klepp O., et al. Norwegian Urology Cancer Group III study group. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol 2010, 58(1):134-140.
41. Wortel R.C., Alemayehu W.G., Incrocci L. Orchiectomy and radiotherapy for stage I-II testicular seminoma: a prospective evaluation of short-term effects on body image and sexual function. J Sex Med 2015, 12:210-218.
42. Arai Y., Kawakita M., Okada Y., et al. Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 1997, 15(4):1444-1448.
43. Rossen P., Pedersen A.F., Zachariae R., et al. Sexuality and body image in long-term survivors of testicular cancer. Eur J Cancer 2012, 48(4):571-578.
44. Bloom J.R., Fobair P., Gritz E., et al. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 1993, 11(5):979-988.
45. Tal R., Stember D.S., Logmanieh N., et al. Erectile dysfunction in men treated for testicular cancer. BJU Int 2014, 113(6):907-910.
46. Choy J.T., Brannigan R.E. The determination of reproductive safety in men during and after cancer treatment. Fertil Steril 2013, 100(5):1187-1191.
47. Hartmann J.T., Albrecht C., Schmoll H.J., et al. Longterm effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer 1999, 80(5-6):801-807.
48. Nangia A.K., Krieg S.A., Kim S.S. Clinical guidelines for sperm cryopreservation in cancer patients. Fertil Steril 2013, 100(5):1203-1209.
49. Choy J.T., Wiser H.J., Bell S.W., et al. Predictors of spermatogenesis in orchiectomy specimens. Urology 2013, 81(2):288-292.
50. Schrader M., Müller M., Sofikitis N., et al. "Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines?. Urology 2003, 61(2):421-425.
51. Furuhashi K., Ishikawa T., Hashimoto H., et al. Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients. Andrologia 2013, 45(2):107-110.
52. Haddad N., Al-Rabeeah K., Onerheim R., et al. Is ex vivo microdissection testicular sperm extraction indicated for infertile men undergoing radical orchiectomy for testicular cancer? Case report and literature review. Fertil Steril 2014, 101(4):956-959.
53. Hsiao W., Stahl P.J., Osterberg E.C., et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the weill cornell experience. J Clin Oncol 2011, 29(12):1607-1611.
54. Nahata L., Cohen L.E., Yu R.N. Barriers to fertility preservation in male adolescents with cancer: it's time for a multidisciplinary approach that includes urologists. Urology 2012, 79(6):1206-1209.
55. Sadri-Ardekani H., Akhondi M.M., Vossough P., et al. Parental attitudes toward fertility preservation in boys with cancer: context of different risk levels of infertility and success rates of fertility restoration. Fertil Steril 2013, 99(3):796-802.
56. Di Pietro M.L., Teleman A.A. Cryopreservation of testicular tissue in pediatrics: practical and ethical issues. J Matern Fetal Neonatal Med 2013, 26(15):1524-1527.
57. Ginsberg J.P., Carlson C.A., Lin K., et al. An experimental protocol for fertility preservation in pre-pubertalboys recently diagnosed with cancer: a report of acceptability and safety. Hum Reprod 2010, 25(1):37-41.
58. Struijk R.B., Mulder C.L., van der Veen F., et al. Restoring fertility in sterile childhood cancer survivors by autotransplanting spermatogonial stem cells: are we there yet?. Biomed Res Int 2013, 2013:903142.